I remain bullish and heavily invested. But I've become pretty sure the optimal window to IPO all of theses incredibile Covid initiatives we've made has passed. TOMDF leadership should be commended. They've put it all together faster, and arguably better than anyone. But Covid will be a thing of the past soon enough, or even if it's not, that won't be a popular investment area. I do think the company has a good chance of collecting a lot of cash over the next 6 months. And that cash will undoubtedly mean something, especially with assets to develop, but that cash has an end. This becomes an R&D Diagnostic company, hopefully with substantial capital. And AMBS should be able to make its nut, but not like I'd hoped. I continue to watch for debt relief from the courts and advancements on our many other fronts, keeping in mind, one small thing is exponential upside.
Amarantus Bioscience Holdings (AMBS) Stock Research Links